Skip to main content
Log in

Use of hospital services by breast cancer patients by stage of the disease: implications on the costs of cancer control

  • Report
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Summary

The use of resources for breast cancer during the first five years after diagnosis by different stages of disease was evaluated on the basis of all breast cancer patients (555) diagnosed in the Tampere University hospital district (Finland). All outpatient visits or inpatient-days of these patients in any hospital of the district were recorded and the average costs of hospital-day and of outpatient visit were applied to quantify the total use of resources. During the first five years of follow-up 535 breast cancer patients had 8206 follow-up visits and spent 18472 days in hospital. The stage II–IV patients had more than twice as many outpatient visits and inpatient-days as the stage I patients. The number of hospital-days/patient-year was 2.4-fold for stage II patients and 4.1-fold for stage III–IV patients as compared to stage I patients. The overall use of resources/ patient for those with nonlocalized disease was twice as high as the use for stage I patients, while the use of resources/person-year was 2.3-fold for stage II patients and 3.6-fold for stage III–IV as compared to stage I patients. Our study in an unselected patient population during the first five years of follow-up shows that breast cancer patients diagnosed in the early stage (stage I) require far fewer health care resources than if diagnosed in advanced stages. The results can be directly transformed into costs of breast cancer control by stage of breast cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Bailar J, Smith E: Progress against cancer. N Engl J Med 314: 1226–1232, 1986

    PubMed  Google Scholar 

  2. McLelland R: Low-cost mass screening with mammography as a means of reducing overall mortality from breast cancer. Rad Clin North Am 25: 1007–1013, 1987

    Google Scholar 

  3. Tabar L, Fagerberg G, Gad Aet al.: Reduction in mortality from breast cancer after mass screening with mammography. Lancet 1: 829–832, 1985

    PubMed  Google Scholar 

  4. Verbeek A, Hendriks J, Holland R, Mravunac M, Sturmans F, Day N: Reduction of breast cancer mortality through mass screening with modern mammography. Lancet 1: 1222–1224, 1984

    PubMed  Google Scholar 

  5. Shapiro S, Venet W, Strax P, Venet L, Roesner R: Ten-tofourteen year effect of screening on breast cancer mortality. JNCI 69: 349–355, 1982

    PubMed  Google Scholar 

  6. Moskowitz M: Costs of screening for breast cancer. Rad Clin North Am 25: 1031–1037, 1987

    Google Scholar 

  7. Hakulinen T, Pukkala E, Hakama M, Lehtonen M, Saxen E, Teppo L: Survival of cancer patients in Finland in 1953–1974. Ann Clin Res 13, suppl 31, 1981

    Google Scholar 

  8. Holli K: Organization, functions, and effectiveness of follow-up for breast cancer patients (in Finnish with English summary). Tampere: Acta Universitatis Tamperensis, Ser A, 225, 1987

  9. Finnish Community Union. Costs of Finnish hospitals and primary health care centers in 1991 (in Finnish), 1993

  10. Drummond M, Stoddart G, Torrance: Methods for the economic evaluation of health care programmes. Oxford: Oxford Medical Publication, 1987

    Google Scholar 

  11. Valentin J, Leitz W: Mass screening for breast cancer. Benefits, risks, costs. Med Oncol & Tumor Pharmacother 5: 77–83, 1988

    Google Scholar 

  12. Van der Maas P, de Koning H, van Ineveld Bet al.: The costeffectiveness of breast cancer screening. Int J Cancer 43: 1055–1060, 1989

    PubMed  Google Scholar 

  13. De Koning H, van Ineveld M, van Oortmarssen Get al.: Breast cancer screening and cost-effectiveness; policy alternatives, quality of life considerations and the possible impact of uncertain factors. Int J Cancer 49: 531–537, 1991

    PubMed  Google Scholar 

  14. Epstein R: Does the breast cancer dollar make sense? Eur J Cancer 28: 486–491, 1992

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kaija, H., Matti, H. & Tapani, H. Use of hospital services by breast cancer patients by stage of the disease: implications on the costs of cancer control. Breast Cancer Res Tr 37, 237–241 (1996). https://doi.org/10.1007/BF01806505

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01806505

Key words

Navigation